Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Recs

0
Player Avatar rocknpopstocks (< 20) Submitted: 1/28/2011 12:32:42 PM : Outperform Start Price: $2.82 ARRY Score: +19.68

Could show serious growth of this decade.

Featured Broker Partners


Advertisement